Cargando…

Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer

Cancer is a leading cause of death and disability worldwide. Epigenetic deregulation is one of the most critical mechanisms in carcinogenesis and can be classified into effects on DNA methylation and histone modification. MicroRNAs are small noncoding RNAs involved in fine-tuning their target genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Mortazavi, Deniz, Sohrabi, Behnoush, Mosallaei, Meysam, Nariman-Saleh-Fam, Ziba, Bastami, Milad, Mansoori, Yaser, Daraei, Abdolreza, Zununi Vahed, Sepideh, Navid, Shadan, Saadatian, Zahra, Jamialahmadi, Tannaz, Teng, Yong, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789461/
https://www.ncbi.nlm.nih.gov/pubmed/35087589
http://dx.doi.org/10.1155/2022/4889807
_version_ 1784639769074991104
author Mortazavi, Deniz
Sohrabi, Behnoush
Mosallaei, Meysam
Nariman-Saleh-Fam, Ziba
Bastami, Milad
Mansoori, Yaser
Daraei, Abdolreza
Zununi Vahed, Sepideh
Navid, Shadan
Saadatian, Zahra
Jamialahmadi, Tannaz
Teng, Yong
Sahebkar, Amirhossein
author_facet Mortazavi, Deniz
Sohrabi, Behnoush
Mosallaei, Meysam
Nariman-Saleh-Fam, Ziba
Bastami, Milad
Mansoori, Yaser
Daraei, Abdolreza
Zununi Vahed, Sepideh
Navid, Shadan
Saadatian, Zahra
Jamialahmadi, Tannaz
Teng, Yong
Sahebkar, Amirhossein
author_sort Mortazavi, Deniz
collection PubMed
description Cancer is a leading cause of death and disability worldwide. Epigenetic deregulation is one of the most critical mechanisms in carcinogenesis and can be classified into effects on DNA methylation and histone modification. MicroRNAs are small noncoding RNAs involved in fine-tuning their target genes after transcription. Various microRNAs control the expression of histone modifiers and are involved in a variety of cancers. Therefore, overexpression or downregulation of microRNAs can alter cell fate and cause malignancies. In this review, we discuss the role of microRNAs in regulating the histone modification machinery in various cancers, with a focus on the histone-modifying enzymes such as acetylases, deacetylases, methyltransferases, demethylases, kinases, phosphatases, desumoylases, ubiquitinases, and deubiquitinases. Understanding of microRNA-related aberrations underlying histone modifiers in pathogenesis of different cancers can help identify novel therapeutic targets or early detection approaches that allow better management of patients or monitoring of treatment response.
format Online
Article
Text
id pubmed-8789461
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87894612022-01-26 Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer Mortazavi, Deniz Sohrabi, Behnoush Mosallaei, Meysam Nariman-Saleh-Fam, Ziba Bastami, Milad Mansoori, Yaser Daraei, Abdolreza Zununi Vahed, Sepideh Navid, Shadan Saadatian, Zahra Jamialahmadi, Tannaz Teng, Yong Sahebkar, Amirhossein J Oncol Review Article Cancer is a leading cause of death and disability worldwide. Epigenetic deregulation is one of the most critical mechanisms in carcinogenesis and can be classified into effects on DNA methylation and histone modification. MicroRNAs are small noncoding RNAs involved in fine-tuning their target genes after transcription. Various microRNAs control the expression of histone modifiers and are involved in a variety of cancers. Therefore, overexpression or downregulation of microRNAs can alter cell fate and cause malignancies. In this review, we discuss the role of microRNAs in regulating the histone modification machinery in various cancers, with a focus on the histone-modifying enzymes such as acetylases, deacetylases, methyltransferases, demethylases, kinases, phosphatases, desumoylases, ubiquitinases, and deubiquitinases. Understanding of microRNA-related aberrations underlying histone modifiers in pathogenesis of different cancers can help identify novel therapeutic targets or early detection approaches that allow better management of patients or monitoring of treatment response. Hindawi 2022-01-11 /pmc/articles/PMC8789461/ /pubmed/35087589 http://dx.doi.org/10.1155/2022/4889807 Text en Copyright © 2022 Deniz Mortazavi et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Mortazavi, Deniz
Sohrabi, Behnoush
Mosallaei, Meysam
Nariman-Saleh-Fam, Ziba
Bastami, Milad
Mansoori, Yaser
Daraei, Abdolreza
Zununi Vahed, Sepideh
Navid, Shadan
Saadatian, Zahra
Jamialahmadi, Tannaz
Teng, Yong
Sahebkar, Amirhossein
Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer
title Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer
title_full Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer
title_fullStr Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer
title_full_unstemmed Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer
title_short Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer
title_sort epi-mirnas: regulators of the histone modification machinery in human cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789461/
https://www.ncbi.nlm.nih.gov/pubmed/35087589
http://dx.doi.org/10.1155/2022/4889807
work_keys_str_mv AT mortazavideniz epimirnasregulatorsofthehistonemodificationmachineryinhumancancer
AT sohrabibehnoush epimirnasregulatorsofthehistonemodificationmachineryinhumancancer
AT mosallaeimeysam epimirnasregulatorsofthehistonemodificationmachineryinhumancancer
AT narimansalehfamziba epimirnasregulatorsofthehistonemodificationmachineryinhumancancer
AT bastamimilad epimirnasregulatorsofthehistonemodificationmachineryinhumancancer
AT mansooriyaser epimirnasregulatorsofthehistonemodificationmachineryinhumancancer
AT daraeiabdolreza epimirnasregulatorsofthehistonemodificationmachineryinhumancancer
AT zununivahedsepideh epimirnasregulatorsofthehistonemodificationmachineryinhumancancer
AT navidshadan epimirnasregulatorsofthehistonemodificationmachineryinhumancancer
AT saadatianzahra epimirnasregulatorsofthehistonemodificationmachineryinhumancancer
AT jamialahmaditannaz epimirnasregulatorsofthehistonemodificationmachineryinhumancancer
AT tengyong epimirnasregulatorsofthehistonemodificationmachineryinhumancancer
AT sahebkaramirhossein epimirnasregulatorsofthehistonemodificationmachineryinhumancancer